ACADIA Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (70)

Latest Posts

About This Stock More About This Stock
This Biotech Looks Good With Increased M&A Activity
Article By: InvestorsAlley
Friday, May 20, 2022 3:49 AM EDT
Fierce Biotech backs this up: “Biopharmas have $1.7 trillion to spend on deals this year, and big players like Novartis, Pfizer and Merck & Co. have made it pretty clear they’re on the hunt for acquisitions.
In this article: ACAD, EXEL, XBI
Futures Flat As Yen Discombobulation Extends To Record 13th Day
Article By: Tyler Durden
Tuesday, April 19, 2022 10:35 AM EDT
After some jerky rollercoaster moves in Monday's illiquid trading session, which jerked both higher and lower before closing modestly in the green.
Acadia: Helping With Alzheimers And Parkinsons
Article By:
Sunday, April 3, 2022 1:15 PM EDT
Things always change fast in biotech, but until recently things have been moving consistently to the downside. It’s been a while, but we believe this is finally over. And we believe Acadia Pharmaceuticals may benefit.
In this article: ACAD Also: XBI
10 Monster Stock Market Predictions For The Week Of June 14
Article By: Michael J. Kramer
Sunday, June 13, 2021 1:22 PM EDT
The big question is what’s next for the S&P 500. Monday morning will likely decide what happens next. It would not be surprising to a reversion to the beginning of the wedge at 4070 over the next couple of weeks.
In this article: C, ICE, ACAD, AAPL, EWJ, SPY, TLT, XLF, DJT
Stocks Drop On May 4 As Taper And Rate Hike Fear Grow
Article By: Michael J. Kramer
Tuesday, May 4, 2021 10:17 PM EDT
Stocks finished the day lower despite an end-of-day surge, leaving the S&P 500 down roughly 70 bps, while the NASDAQ QQQ ​​​​​​​fell by 1.8%.
In this article: ACAD, BITCOMP, SQ, AMZN, SPX, QQQ

Latest Tweets for $ACAD

No tweets yet!



Key Catalysts For ACADIA Pharmaceuticals
John Doee 6/8/2020 3:46:48 AM

What do you think specifically has helped $ACAD thrive during the Pandemic? While they are focusing on the development of drugs unrelated to COVID-19, how were they able to thrive?

Sunday Trio Of Short Ideas
All Things Tech 8/28/2017 3:36:31 AM

100% agreement on $BWLD especially since it has been flat for months in a bullish market with more room to fall.

I disagree with $AMD. If AMD falls below the SMA200, absolutely short, but the Triple Bottom off 12.00 is a cause of concern + a previous ER beat + Q3 ER beat likely & sitting in oversold territory according to (MFI). $SOXX shows a Pennant as well.

$ACAD long-term is down, but short term is up. Above the SMA 20, 50 & 200.

Both AMD & ACAD is big risk little reward in my book unless the Days to Cover is a big enough window. Otherwise just not worth it in my book.

1 to 2 of 2 comments